Tizanidine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain
Condition:   Acute Muscle Pain Interventions:   Drug: SPARC1401-low dose;   Drug: SPARC1401-mid dose;   Drug: SPARC1401-high dose;   Drug: Reference1401 (Tizanidine);   Drug: Placebo1401 Sponsor:   Sun Pharma Advanced Research Company Limited Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2016 Category: Research Source Type: clinical trials